High levels of lipoprotein(a) - assessment and treatment
- PMID: 36655975
- DOI: 10.4045/tidsskr.21.0800
High levels of lipoprotein(a) - assessment and treatment
Abstract
Approximately 5 % of the population have highly elevated levels of lipoprotein(a) (Lp(a)), which is a genetically determined risk factor for cardiovascular disease. Measuring lipoprotein(a) can improve cardiovascular risk stratification and have consequences for preventive measures. Treatment is targeted at reducing modifiable cardiovascular risk factors, but Lp(a)-lowering drugs are being trialled. This article reviews the management of lipoprotein(a) in clinical practice.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous